In order to obtain this action we must pay 11,60$ right now, Y mAbs Therapeutics, with address at 230 PARK AVENUE SUITE 3350, NEW YORK, New York, 10169, United States, is a publicly traded company and its visible heads at the moment are Bo Kruse (CFO, Secretary. Treasurer & Executive VP), Claus Juan M°ller-San Pedro (Chief Executive Officer & Director), Joris Wiel Jan Wilms (Chief Operating Officer & Senior Vice President), Steen Lisby (Chief Scientific Officer & Senior Vice President), Torben Lund-Hansen (Chief Technology Officer & Senior Vice President), Vignesh Rajah (Chief Medical Officer & Senior Vice President). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 11,50$ - 12,02$, with a percentage difference of 11,76$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.